Cited by 61Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

The longitudinal evaluation of familial frontotemporal dementia subjects protocol: framework and methodology

Open access
Boeve, Bradley, Bove, Jessica, Brannelly, Patrick, Brushaber, Danielle, Coppola, Giovanni, Dever, Rielly, Dheel, Christina, Dickerson, Bradford +54 more·2020·Alzheimer's & Dementia

Abstract

Introduction: It is important to establish the natural history of familial frontotemporal lobar degeneration (f‐FTLD) and provide clinical and biomarker data for planning these studies, particularly in the asymptomatic phase. Methods: The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects protocol was designed to enroll and follow at least 300 subjects for more than at least three annual visits who are members of kindreds with a mutation in one of the three most common f‐FTLD genes—microtubule‐associated protein tau, progranulin, or chromosome 9 open reading frame 72. Results: We present the theoretical considerations of f‐FTLD and the aims/objectives of this protocol. We also describe the design and methodology for evaluating and rating subjects, in which detailed clinical and neuropsychological assessments are performed, biofluid samples are collected, and magnetic resonance imaging scans are performed using a standard protocol. Discussion: These data and samples, which are available to interested investigators worldwide, will facilitate planning for upcoming disease‐modifying therapeutic trials in f‐FTLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.06.4947

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration Consortium involves 23 sites in North America and has evaluated over 1500 participants so far.

    “ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration Consortium, which involves 23 sites in North America and has evaluated over 1500 participants so far.2,65,94”

    From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [94]

    The Study Design > Recruitment section identifies LEFFTDS and the closely related ARTFL protocol, and the Procedures > Clinical arm section describes their shared measures. Our copy does not substantiate 23 North American sites or over 1,500 participants evaluated; its Study Design > Overview instead gives a planned LEFFTDS enrollment of at least 300. No page numbers are provided in the indexed passages. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 77 · Cited by 61

Research works printed but not linked: 1

  1. [64]Knopman DS, Weintraub S, Pankratz VS. Language and behavior domains enhance the value of the clinical dementia rating scale. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2011; 7: 293– 9. PMC3096831 21575870

Authors
Boeve, B., Bove, J., Brannelly, P., Brushaber, D., Coppola, G., Dever, R., Dheel, C., Dickerson, B., Dickinson, S., Faber, K., Fields, J., Fong, J., Foroud, T., Forsberg, L., Gavrilova, R., Gearhart, D., Ghoshal, N., Goldman, J., Graff‐Radford, J., Graff‐Radford, N., Grossman, M., Haley, D., Heuer, H., Hsiung, G. R., Huey, E., Irwin, D., Jones, D., Jones, L., Kantarci, K., Karydas, A., Knopman, D., Kornak, J., Kraft, R., Kramer, J., Kremers, W., Kukull, W., Lapid, M., Lucente, D., Mackenzie, I., Manoochehri, M., McGinnis, S., Miller, B., Pearlman, R., Petrucelli, L., Potter, M., Rademakers, R., Ramos, E. M., Rankin, K., Rascovsky, K., Sengdy, P., Shaw, L., Syrjanen, J., Tatton, N., Taylor, J., Toga, A., Trojanowski, J., Weintraub, S., Wong, B., Wszolek, Z., Boxer, A., Rosen, H., & on Behalf of the LEFFTDS Consortium
Affiliations
  • Mayo Clinic (US)
  • University of Pennsylvania (US)
  • Rainwater Charitable Foundation (US)
  • University of California, Los Angeles (US)
  • University of California, San Francisco (US)
  • Harvard University (US)
  • Association for Frontotemporal Degeneration (US)
  • Indiana University Indianapolis (US)
  • Washington University in St. Louis (US)
  • Columbia University (US)
  • Mayo Clinic in Florida (US)
  • University of British Columbia (CA)
  • University of Washington (US)
  • University of Southern California (US)
Corresponding author
Boeve, Bradley
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2020-01
Volume
16
Issue
1
Pages
22-36
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2980420390
Cited by
61
References
77
Citations by year
2026: 9 · 2025: 9 · 2024: 10 · 2023: 7 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 2
FWCI
5.17
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
National Institutes of Health (U01 AG045390)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
familial frontotemporal lobar degeneration, natural history (disease)
MeSH terms
C9orf72 Protein, Adult, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Mutation, Neuropsychological Tests, tau Proteins, Genetic Predisposition to Disease, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review